Randomized trial evaluates feasibility of remote light therapy for Parkinson’s disease, indicating possible broad access.
To evaluate the feasibility of an entirely remote, decentralized phase 3 clinical trial of an investigative light therapy device for Parkinson’s disease.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: